Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Glioma × capivasertib × Clear all

Sponsor

Conditions

Triple Negative Breast Neoplasms 2 Recurrence 1 Neoplasms 1 Multiple Myeloma 1 Lymphoma, Mantle-Cell 1 Lymphoma, Follicular 1 Lymphoma, B-Cell, Marginal Zone 1 Lymphoma, B-Cell 1 Lymphoma 1 Locally Advanced (Inoperable) or Metastatic Breast Cancer 1 Hematologic Neoplasms 1 Carcinosarcoma 1 Carcinoma, Endometrioid 1 Breast Neoplasms 1 Advanced Solid Malignancy, 1

Interventions

Temozolomide 47 Bevacizumab 41 Radiotherapy 17 Magnetic Resonance Spectroscopy 14 Irinotecan 11 Nivolumab 8 Everolimus 7 Radiation 6 X-Rays 5 Phantoms, Imaging 5 Carboplatin 5 poly ICLC 4 pembrolizumab 4 fluorodopa F 18 4 Specimen Handling 4 Nuclear Medicine Department, Hospital 4 Erlotinib Hydrochloride 4 Carmustine 4 ribociclib 3 palbociclib 3 ivosidenib 3 antineoplaston A10 3 Vorinostat 3 Radiotherapy, Intensity-Modulated 3 Radiosurgery 3 Modafinil 3 Lomustine 3 Granulocyte-Macrophage Colony-Stimulating Factor 3 Biopsy 3 veliparib 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡